Viewing StudyNCT00005857



Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00005857
Status: COMPLETED
Last Update Posted: 2011-10-20
First Post: 2000-06-02

Brief Title: Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
Sponsor: City of Hope Medical Center
Organization: City of Hope Medical Center

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
recurrent prostate cancer View
stage IV prostate cancer View